Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity-Reference-Cited by-同舟云学术

Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity

Published:2013-04 Issue:4 Volume:21 Page:904-912
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Lamers Cor HJ,Sleijfer Stefan,van Steenbergen Sabine,van Elzakker Pascal,van Krimpen Brigitte,Groot Corrien,Vulto Arnold,den Bakker Michael,Oosterwijk Egbert,Debets Reno,Gratama Jan W

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference51 articles.

1. Establishment of antitumor memory in humans using in vitro-educated CD8+ T cells;Butler;Sci Transl Med,2011

2. Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs);Savoldo;Blood,2006

3. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells;Yee;Proc Natl Acad Sci USA,2002

4. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor;Walter;N Engl J Med,1995

5. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma;Dudley;J Clin Oncol,2005

Cited by 580 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineered T cells for Colorectal Cancer;Immunotherapy;2024-09-04

2. The peptide-based bispecific CAR T cells target EGFR and tumor stroma for effective cancer therapy;International Journal of Pharmaceutics;2024-09

3. TYRP1 directed CAR T cells control tumor progression in preclinical melanoma models;Molecular Therapy: Oncology;2024-09

4. Manufacturing CD20/CD19-targeted iCasp9 regulatable CAR-TSCM cells using a Quantum pBac-based CAR-T engineering system;PLOS ONE;2024-08-27

5. CAR T-cell toxicities: from bedside to bench, how novel toxicities inform laboratory investigations;Blood Advances;2024-08-16